Търсене на изпитвания

AI · parkinson

Намерени 50 изпитвания за "parkinson" Стр. 3 от 3

Активно (без набиране) Фаза 2

A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease

Parkinson's Disease (PD)

The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).

Начало: 20.03.2025 Край: 28.11.2026 Възраст: 50–80 г.

United States TrueBinding, Inc. NCT06773962

Активно (без набиране) Фаза 3

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Parkinson Disease

This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424 or 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.

Начало: 20.09.2024 Край: 01.08.2026 Възраст: от 30 г. Лечение

Australia, Czechia, France +6 Cerevance NCT06553027

Активно (без набиране)

Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease 2

Parkinson Disease

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor function in people with Parkinson's disease (PD). vCR will be administered with a device called the Vibrotactile (VT) Touch device. vCR can be used in conjunction with medication and is expected to delay the need to increase dopamine medication. It also provides a more flexible alternative to deep brain stimulation (DBS) in that the vCR therapy can be easily stopped or modified to better suit the patients' needs.

Начало: 12.07.2023 Край: 01.11.2026 Възраст: 45–85 г.

United States Synergic Medical Technologies, Inc. NCT05881460

Активно (без набиране)

Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease

Parkinson's Disease

The purpose of the present research is to examine the effectiveness of a non-invasive, vibrotactile stimulation protocol, known as coordinated reset (CR), for the alleviation of motor symptoms in patients with Parkinson's disease (PD). PD patients exhibit rigidity, slowness (bradykinesia) and poverty (akinesia) of movement as well as other symptoms. Treatment for PD is either pharmacological (first line) or invasive deep brain stimulation. The non-invasive, vibrotactile stimulation approach uses a novel stimulation pattern to disrupt the pathophysiological mechanism that is responsible for PD symptoms and thus restore motor function.

Начало: 01.03.2023 Край: 01.06.2026 Възраст: 45–90 г.

United States Synergic Medical Technologies, Inc. NCT05830110

Активно (без набиране)

Robotic Gait Rehabilitation in Parkinson's Disease

Parkinson Disease Gait Disorder, Sensorimotor

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes. Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability. Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life

Начало: 10.01.2022 Край: 01.12.2026 Възраст: от 18 г.

United States Indiana University NCT05218187

Активно (без набиране)

Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

Advanced Parkinson Disease

This observational study is designed to collect data on the use of the drug Lecigon® in daily clinical practice. The study is organised and funded by a pharmaceutical company called Britannia Pharmaceuticals Ltd (Britannia). Lecigon® is prescribed by physicians in advanced Parkinson's disease when patients suffer from uncontrollable fluctuations in mobility, so-called motor fluctuations, which cannot be adjusted well with oral treatment, i.e. medication for swallowing. In this study, data on the effect and possible side effects from everyday treatment with Lecigon® will be collected and scientifically evaluated. The study is intended to supplement the results of previous clinical studies with clinical data in routine medical care, collected from approximately 300 patients.

Начало: 06.07.2021 Край: 01.09.2026 Възраст: от 18 г.

Austria, Belgium, Bulgaria +11 Britannia Pharmaceuticals Ltd. NCT05043103

Активно (без набиране)

Remote Therapeutic Monitoring Exercise Tracking

Parkinson Disease Multiple Sclerosis

The purpose of this study is to examine physical activity and exercise behaviors in people with Parkinson's Disease and Multiple Sclerosis over the course of 1-year using a cloud-based remote monitoring platform.

Начало: 01.04.2024 Край: 01.03.2028 Възраст: 18–89 г.

United States Shirley Ryan AbilityLab NCT06306768

Само по покана

Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease

PARKINSON DISEASE (Disorder)

Background \& Rationale: Treatment options for Parkinson's Disease (PD) often face challenges due to the variety of clinical subtypes, differing individual responses, and disease progression. Given its portability, affordability, safety, and ease of use, cerebellar transcranial direct current stimulation (ctDCS) presents as a promising option for home-based treatment with medical telemonitoring in the near future. Study Procedures: Participants are invited to complete questionnaires regarding quality of life, anxiety and depression, and symptoms related to their PD. On the first day, they will be assessed using the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III for motor impairment and the Cerebellar Cognitive Affective Syndrome scale (CCAS) for cognitive impairment. Participants will then undergo an additional 8 days of at-home cTDCS stimulation. On the 10th day, they will be reassessed using the MDS-UPDRS III and CCAS. One month later, they will complete again the questionnaires regarding quality of life, anxiety, depression, and symptoms related to their PD. Objective: Consequently, the primary goal is to investigate the effectiveness of ctDCS in addressing both motor and non-motor symptoms of PD

Начало: 24.09.2025 Край: 01.11.2026 Възраст: от 18 г.

Belgium Université Libre de Bruxelles NCT07548801

Само по покана

Intrapatient Comparison of STN and GPi tTIS in PD

Parkinson Disease

The goal of this clinical trial is to investigate the therapeutic efficacy of tTIS in patients with Parkinson's disease and to evaluate the immediate effects and conduct intrapatient comparisons of individualized 130 Hz Subthalamic Nucleus-transcranial Temporal Interference Stimulation (STN-tTIS) and Globus Pallidus Internus-transcranial Temporal Interference Stimulation (GPi-tTIS) on motor symptoms in patients with early to mid-stage Parkinson's Disease (PD) during "off" medication states. The main questions this study aims to answer are: 1. Can tTIS significantly improve the motor symptoms of patients with Parkinson's disease? 2. Is the therapeutic effect of STN-tTIS superior to that of GPi-tTIS?

Начало: 23.04.2025 Край: 01.11.2026 Възраст: 50–85 г.

China Ruijin Hospital NCT07018388

Само по покана

Exercise Strategies in Parkinson's Disease

Parkinson Disease

The goal of this clinical trial is to learn about exercise and physical activity people with Parkinson's Disease. The main questions it aims to answer are: 1) learn about the physical activity and exercise behaviors of people with Parkinson's Disease over the course of a year and 2) compare 3 exercise guidance strategies aimed to impact exercise behavior: standard care, written exercise guidance from neurologist and/or physical therapy. During the course of the study: 1. Participants will use activity trackers and a mobile phone application to monitor their exercise participation. 2. At the same time, the research team will be working with the participant's medical teams at Northwestern Medicine and University of Chicago Medical Center to improve the way that they deliver exercise guidance using verbal instructions and encouragement, written exercise guidance, and/or physical therapy.

Начало: 01.03.2024 Край: 31.05.2028 Възраст: 18–89 г.

United States Shirley Ryan AbilityLab NCT06104397

1 2 3